Patrick Johnston
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Drug Transport and Resistance Mechanisms
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 11
- Colorectal Cancer Treatments and Studies 6
- Cancer-related Molecular Pathways 2
- Chemokine receptors and signaling 2
-
- Acute Myeloid Leukemia Research 2
- Co-authors
- Daniel B. Longley (5 shared papers)Eric Van Cutsem (2 shared papers)Anthi Karaı̈skou (1 shared paper)Leeona Galligan (1 shared paper)Sandra Van Schaeybroeck (2 shared papers)John W. Kugler (1 shared paper)Maria Tria Tirona (1 shared paper)Christopher John Poole (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)Cancer Chemotherapy and Pharmacology (1 paper)Molecular Cancer Therapeutics (1 paper)The Lancet Oncology (1 paper)Expert Opinion on Drug Metabolism & Toxicology (1 paper)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
Patrick Johnston
19 papers receiving 694 citations
Peers
Comparison fields: 5 of 75
- Oncology 359
- Pharmacology 41
- Pathology and Forensic Medicine 68
- Geriatrics and Gerontology 11
- Biological Psychiatry 4
Countries citing papers authored by Patrick Johnston
This map shows the geographic impact of Patrick Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Johnston more than expected).
Fields of papers citing papers by Patrick Johnston
This network shows the impact of papers produced by Patrick Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Johnston. The network helps show where Patrick Johnston may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Johnston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 149 | |
| 2 | 2002 | 109 | |
| 3 | 2005 | 95 | |
| 4 | 2016 | 61 | |
| 5 | 2005 | 57 | |
| 6 | 2002 | 51 | |
| 7 | 2016 | 42 | |
| 8 | 2003 | 40 | |
| 9 | 2008 | 34 | |
| 10 | 2001 | 31 | |
| 11 | 2006 | 22 | |
| 12 | 2007 | 19 | |
| 13 | 2016 | 6 | |
| 14 | CXCR2/NF-kappaB/Bcl-2-survivin signalling pathway promotes resistance to oxaliplatin in metastatic prostate cancer cells | 2006 | 3 |
| 15 | BRCA1 regulates the interferon gamma-mediated apoptotic response. | 2003 | 2 |
| 16 | Interleukin-8/CXCR2 signaling plays an important role in conferring resistance of prostate cancer cells to chemotherapy | 2007 | 2 |
| 17 | 2017 | 2 | |
| 18 | THE PROGNOSTIC ROLE OF C-FLIP IN AML | 2009 | 1 |
| 19 | EpHA2 is an essential driver of invasion and a novel target in KRAS mutant colorectal cancer | 2014 | 1 |
About Patrick Johnston
Patrick Johnston is a scholar working on Oncology, Hematology, Reproductive Medicine, Public Health, Environmental and Occupational Health and Molecular Biology, having authored 19 papers that have together received 727 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (6 papers), Acute Myeloid Leukemia Research (2 papers), Cancer-related Molecular Pathways (2 papers), Health and Medical Research Impacts (2 papers), Prostate Cancer Treatment and Research (2 papers), Cell death mechanisms and regulation (2 papers), Science, Research, and Medicine (2 papers) and Chemokine receptors and signaling (2 papers). The work is most often cited by research in Oncology (359 citations), Pharmacology (41 citations), Pathology and Forensic Medicine (68 citations), Geriatrics and Gerontology (11 citations) and Biological Psychiatry (4 citations). Patrick Johnston has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Daniel B. Longley, Eric Van Cutsem, Anthi Karaı̈skou, Leeona Galligan, Sandra Van Schaeybroeck, John W. Kugler, Maria Tria Tirona, Christopher John Poole, Richard M. Goldberg and K A Behan. Their work appears in journals such as Clinical Cancer Research, Cancer Chemotherapy and Pharmacology, Molecular Cancer Therapeutics, The Lancet Oncology and Expert Opinion on Drug Metabolism & Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.